Tech Company Financing Transactions
Biomason Funding Round
Biomason secured a $65 million Series C financing round on 3/16/2022. Backers included 2150, Celesta Capital and Martin Marietta.
Transaction Overview
Company Name
Announced On
3/16/2022
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to accelerate development of the biocement technology platform to reach its goal of eliminating 25% of global carbon emissions from the concrete industry by 2030.
Company Information
Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
2 Triangle Dr.
Research Triangle Park, NC 27709
USA
Research Triangle Park, NC 27709
USA
Phone
Undisclosed
Website
Email Address
Overview
Biomason is the only company in the world using biology to produce cement commercially. Since 2012, we've used natural microorganisms to grow sustainable, structural biocement in ambient temperatures, harnessing the power of biotechnology to reinvent traditional cement and offer a planet-friendly alternative.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ginger Dosier
Chief Financial Officer
Lily Wachter
Chief Operating Officer
Bert Bruggeman
Chief Technical Officer
Michael Dosier
VP - Administration
Paige Wilcox
VP - Bus. Development
Brandon Cook
VP - Bus. Development
Jan Vandesande
VP - R & D
Kim Anderson
Browse more venture capital transactions:
Prev: 3/16/2022: Qventus venture capital transaction
Next: 3/16/2022: Flashfood venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs